Medelis was founded in 2003 by a group of experienced clinical research oncologists including Dan Von Hoff and Michael Gordon with a vision of delivering oncology expertise at the strategic and tactical level – from protocol development and regulatory guidance to site management and medical writing.
Our therapeutic experts are actively involved with our study team providing expertise in:
Relationships are important to us. Reach out to learn more about how our approach, experience, investigator relationships, bid transparency and flexibility deliver success for our clients.